Privacy Policy

We do not collect any personally identifiable information about you unless you provide it to us voluntarily. If you do not want your personally identifiable information to be collected, please do not submit it to us.

If you do provide us with personally identifiable information, such as your name, postal address, e-mail address, telephone numbers, and other personal information, we may contact you, via e-mail or regular mail, to provide you with information we believe may be of interest to you. At the time, you will be offered the opportunity to opt out of this service. We do not sell or transfer to others outside our company the information you send to us, except that your data may be transferred to an outside fulfillment company for processing and mailing purposes only. We consider your e-mail address and any personal information you give to be private and these data will be kept confidential within the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership and by any outside fulfillment company. Within Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, data may be transferred to or accessed by authorized Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership personnel in other countries. At all times, personal data are treated confidentially.

Data that are not personal, such as questions, comments, ideas, and suggestions, shall be deemed to be nonconfidential, and Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership shall be free to disclose and use the same, without any obligation whatsoever to you, for any purpose and through any means.

In addition, we may store some information on your computer to improve the quality of your visit to our site. In some cases, this information will help us to tailor the content to your interests or help us to avoid asking for the same information on repeat visits to the site. With most Internet browsers, you can erase the information, referred to as "cookies", from your computer's hard drive, block all cookies, or even receive a warning before a cookie is placed on your system. Refer to your browser instructions or help button to learn more about cookies.

We are very concerned about protecting the privacy of children. We do not intend to collect any personally identifiable information from children under 18 years old. If a child has provided us with personally identifiable information, the parent or guardian of that child should contact us at the telephone number below if he or she wants this information deleted from our files.

If you have any questions, comments, or concerns about Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership's data privacy policy, please call 888-786-8637. Also, if you think we may have received information about you inadvertently, or if you wish to delete your personal information from our files, please call us at the above telephone number.

Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership may at any time revise these terms and conditions by updating this posting. You are all bound by any such revisions and should therefore periodically visit this page to review the then current terms and conditions to which you are bound.

Limitation of Liability
Acceptance of Agreement

Your access to and use of the PLAVIX.com Web site (the "Site") is subject to the following terms and conditions and all applicable laws. By accessing and browsing the Site, you accept and agree to, without limitation or qualification, the terms and conditions and acknowledge that any other agreements between you and Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership's are superseded and of no force or effect with respect to your access and use of the Site.

Scope of Use

Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership maintains the Site for your personal information, education, and communication. Please feel free to browse the Site. You may download material displayed on the Site for non-commercial, personal use only, provided you maintain all copyright and other proprietary notices contained on the materials. You may not, however, distribute, modify, transmit, reuse, repost, or use the content of the Site for public or commercial purposes, including the text and images, without Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership's written permission. You understand that Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership makes no representation that the information in the Site is appropriate or available for use in locations outside of the United States, and access to the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership Site from territories where the content of the Site may be illegal or inappropriate is prohibited. Those who choose to access the Site from other locations do so on their own initiative and are responsible for compliance with applicable local laws.

No Medical Advice

The Site does not provide medical advice. With limited exception, Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership products are available only by prescription from a licensed health-care professional. Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership is not engaged in rendering medical or similar professional services or advice, and the information provided on the Site is not intended to replace medical advice offered by a health-care provider. If you desire or need such services or advice, you should promptly consult a physician or professional health-care provider.

Product Information

The product information provided on the Site is intended only for residents in the United States. The Site and its links may, however, contain information about products that may or may not be available in any particular country, territory or region of the world (including the United States), may be available under different trademarks in different countries and, where applicable, may be approved or cleared by a government regulatory body for sale or use with different indications and restrictions in different countries. You should not construe anything on the Site as a promotion or solicitation for any product or service or for the use of any product or service that is not authorized by the laws and regulations of the country where you are located, including the United States. For specific information about particular products, you should refer to the full prescribing information as approved by the relevant governmental authority of the country where you are located. The prescribing information provided here is based on United States labeling and may not be appropriate outside of the United States.

Copyright Protection

You should assume that everything you see or read on the Site is copyrighted, unless otherwise noted, and may not be used except as provided in these terms and conditions or in the text on the Site without the written permission of Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership. Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership neither warrants nor represents that your use of materials displayed on the Site will not infringe rights of third parties not owned by or affiliated with Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.

Trademarks

The trademarks, tradenames, logos, and service marks (collectively the "Trademarks") displayed on the Site are registered and unregistered Trademarks of Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership and others. Nothing contained on the Site should be construed as granting, by implication, estoppel, or otherwise, any license or right to use any Trademark displayed on the Site without the written permission of Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership or such third party that may own the Trademarks displayed on the Site. Your use of the Trademarks displayed on the Site, or any other content on the Site, except as provided in these terms and conditions, is strictly prohibited. You are also advised that Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership will aggressively enforce its intellectual property rights to the fullest extent of the law, including the seeking of criminal prosecution.

Exclusion of Warranty

While Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership uses reasonable efforts to include accurate and up-to-date information in the Site, Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership makes no warranties or representations as to its accuracy. Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership assumes no liability or responsibility for any errors or omissions in the content of the Site. Without limiting the foregoing, everything on the Site is provided to you "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT. Please note that some jurisdictions may not allow the exclusion of implied warranties, so some of the above exclusions may not apply to you. Check your local laws for any restrictions or limitations regarding the exclusion of implied warranties.

Limitation of Liability

Your use of and browsing in the Site are at your risk. Neither Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership nor any other party involved in creating, producing, or delivering the Site is liable for any direct, incidental, consequential, indirect, or punitive damages arising out of your access to, or use of, the Site. Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership assumes no responsibility, and shall not be liable for, any damages to, or viruses that may infect, your computer equipment or other property on account of your access to, use of, or browsing in the Site or your downloading of any materials, data, text, or images from the Site.

Prohibited Transmissions

Certain areas of the Site may enable you to access online forums and to submit e-mails, or otherwise provide feedback to Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership. Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership does not endorse, and specifically disclaims, any responsibility or liability for any content in these fora. You may not post or transmit any unlawful, threatening, libelous, defamatory, obscene, indecent, inflammatory, pornographic or profane material or any material that could constitute or encourage conduct that would be considered a criminal offense, give rise to civil liability, or otherwise violate any law. In addition, you are prohibited from posting or transmitting any information which (a) infringes the rights of others or violates their privacy or publicity rights, (b) is protected by copyright, trademark or other proprietary right, unless with the express written permission of the owner of such right, (c) contains a virus, bug or other harmful item, or (d) is used to unlawfully collude against another person in restraint of trade or competition. You shall be solely liable for any damages resulting from any infringement of copyright, trademark, or other proprietary right, or any other harm resulting from your use of the Site.

User Submissions

Any "personally identifiable information" in electronic communications to the Site is governed by the Site's Privacy Policy. On the other hand, any communication or material you transmit to the Site by electronic mail or otherwise, including any data, questions, comments, suggestions, or the like is, and will be treated as, non-confidential and non-proprietary. You understand that anything you transmit or post may be used by Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership or its affiliates for any purpose, including, but not limited to, reproduction, disclosure, transmission, publication, broadcast, and posting. Furthermore, Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership is free to use any ideas, concepts, know-how, processes, or techniques contained in any communication you send to the Site for any purpose whatsoever including, but not limited to, developing, manufacturing, marketing, and selling products and service using such ideas, concepts, know-how, processes, or techniques.

Links to Other Sites

Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership has not reviewed all of the sites linked to the Site and is not responsible for the content of any off-site pages or any other sites linked to the Site. Your linking to any other off-site pages or other sites is at your own risk. Once you link to another site, please be sure to review the legal notice and privacy policy of the new site. It may be different from those governing the Site.

Governing Law

This agreement and its performance shall be governed by the laws of the state of New Jersey, United States of America, without regard to its conflict of laws provisions. You consent and submit to the exclusive jurisdiction of the state and federal courts located in Mercer County, the state of New Jersey, United States of America, in all questions and controversies arising out of your use of the Site and this Agreement. To the extent allowed by applicable law, any claim or cause of action arising from or relating to your access or use of the Site must be brought within two (2) years from the date on which such claim or action arose or accrued.

Modification of Agreement

Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership may, at any time, revise the terms and conditions of this agreement governing use of the Site. If any terms and conditions contained in this Legal Notice are changed, the amended notice will be posted on the Site. You are bound by any such revisions and should, therefore, periodically review these terms and conditions.

Important Information

If you have a stomach ulcer or other condition that causes bleeding, you shouldn't use PLAVIX. When taking PLAVIX alone or with some medicines including aspirin, the risk of bleeding may increase. To minimize this risk, talk to your doctor before taking aspirin or other medicines with PLAVIX. Additional rare but serious side effects could occur.

Please see full prescribing information.

Remember, your doctor is the single best source of information regarding your health. Please consult your doctor if you have any questions about your health or your medicine.

The information on this site is intended for residents of the United States.

Indications
Use PLAVIX plus aspirin for patients with non–ST–segment elevation acute coronary syndrome (UA/non–Q–wave MI), including patients to be managed medically and those to be managed with percutaneous coronary intervention (with or without stent) or CABG, to decrease the rate of a combined end point of CV death, MI, or stroke as well as the rate of a combined end point of CV death, MI, stroke, or refractory ischemia.

Use PLAVIX plus aspirin for patients with ST–segment elevation acute myocardial infarction to reduce the rate of death from any cause and the rate of a combined end point of death, reinfarction, or stroke. This benefit is not known to pertain to patients who receive primary angioplasty.

Use PLAVIX alone for patients with a history of recent stroke, recent MI, or established PAD to reduce the rate of a combined end point of new ischemic stroke (fatal or not), new MI (fatal or not), and other vascular death.
Important Risk Information 18
PLAVIX is contraindicated in patients with active pathologic bleeding such as peptic ulcer or intracranial hemorrhage. PLAVIX should be used with caution in patients who may be at risk of increased bleeding from trauma, surgery, or coadministration with NSAIDs or warfarin. (See CONTRAINDICATIONS and PRECAUTIONS.*)

The rates of major and minor bleeding were higher in patients treated with PLAVIX plus aspirin compared with placebo
plus aspirin in clinical trials. (See ADVERSE REACTIONS.*)

As part of the worldwide post–marketing experience with PLAVIX, there have been cases of reported thrombotic thrombocytopenic purpura (TTP), some with fatal outcome. TTP has been reported rarely following use of PLAVIX, sometimes after a short exposure (<2 weeks). TTP is a serious condition that can be fatal and requires urgent treatment including plasmapheresis (plasma exchange). (See WARNINGS.*)

In clinical trials, the most common clinically important side effects were pruritus, purpura, diarrhea, and rash; infrequent events included intracranial hemorrhage (0.4%) and severe neutropenia (0.05%). (See ADVERSE REACTIONS.*)